GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Total Debt per Share

The Cooper (MEX:COO) Total Debt per Share : MXN259.29 (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is The Cooper Total Debt per Share?

MXN259.29 (As of Oct. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. The Cooper's Total Debt Per Share for the quarter that ended in Oct. 2024 was MXN259.29.

The Cooper Total Debt per Share Historical Data

The historical data trend for The Cooper's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Total Debt per Share Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 223.52 154.34 278.13 234.14 259.29

The Cooper Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 234.14 239.65 232.52 245.89 259.29

The Cooper Total Debt per Share Calculation

The Cooper's Total Debt Per Share for the fiscal year that ended in Oct. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(51,088+667)/200
=259.29

The Cooper's Total Debt Per Share for the quarter that ended in Oct. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(51,088+667)/200
=259.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Total Debt per Share Related Terms

Thank you for viewing the detailed overview of The Cooper's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Total Debt per Share
Comparable Companies
HOLX WST BAX ALGN AVTR ATR TFX RGEN MMSI STVN ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XSWX:STMN TSE:7733
Traded in Other Exchanges
COO:USA 0I3I:UK CP60:Germany CP60:Germany C1OO34:Brazil
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
Website
https://www.coopercos.com
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.